Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

KB-099520 increases serotonergic activity and demonstrates antidepressant effects

Oct. 26, 2009

Preclinical characterization of SEP-230864 presented by Sepracor

Oct. 26, 2009

PSN-0041 displays enhanced antidepressant activity over native amylin in preclinical tests

Oct. 26, 2009

Phase I study results encourage further development of anesthetic PF-0713

Oct. 26, 2009

Dienogest exhibits favorable safety profile in the long-term treatment of endometriosis

Oct. 26, 2009

The GnRH antagonist TAK-38 has potential for the treatment of endometriosis

Oct. 23, 2009

AMR-MCH-14 reduces food intake and body fat in preclinical model of obesity

Oct. 23, 2009

Aminophylline reverses midazolam sedation in healthy volunteers

Oct. 23, 2009

Rolapitant similar to ondansetron in treating postoperative nausea and vomiting

Oct. 23, 2009

Non-selective opioid modulator RDC-5768 reduces behavioral effects of drugs of abuse

Oct. 23, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...